Cite

HARVARD Citation

    Lee, K. et al. (2016). Eligibility for Pcsk9 Therapy in Cholesterol Center Patients with Initial ldl Cholesterol ≥130 but ≪160 Mg/Dl. Journal of investigative medicine. 64 (4), p. 923. [Online]. 
  
Back to record